Dr Shane Hegarty is Chief Scientific Officer, Co-Founder and IP Co-Inventor at AXONIS Therapeutics, a Boston-based biotechnology company. He has 15+ years of experience leading cutting-edge, award-winning neuro-protection, -modulation and -regeneration research for neurological disorders. In recent years, Shane has completed a number of competitive biotech entrepreneurial programs, such as Creative Destruction Labs and Harvard I-Labs. As a Research Fellow in Professor Zhigang He’s lab in Boston Children’s Hospital and Harvard Medical School, Dr. Hegarty led in vivo phenotypic screens, such as a genome-wide AAV-CRISPR screen for neuro-protection and -regeneration in a CNS injury model.